Medical Leadership
JASON STEPKOVITCH, MD
Founder & Medical Director Psychiatrist | Interventional Psychiatry | Treatment-Resistant Depression
Dr. Jason Stepkovitch founded CNY Psychiatry in 2019 and leads its interventional psychiatry program, with a particular clinical interest in treatment-resistant depression, TMS, accelerated TMS, IV ketamine, and Spravato®. His approach emphasizes careful diagnosis, thoughtful patient selection, and direct psychiatric oversight of advanced treatments. He believes interventional treatments are most valuable when incorporated into comprehensive psychiatric care with the objective of achieving meaningful, sustainable recovery.
Dr. Jason Stepkovitch is the founder and Medical Director of CNY Psychiatry, a Central New York psychiatric practice focused on the evaluation and treatment of patients whose symptoms have not adequately improved with conventional care.
He founded CNY Psychiatry in 2019 with an initial focus on expanding access to TMS. The practice has since developed into a broader interventional psychiatry program providing TMS, accelerated TMS, Spravato® (esketamine), and IV ketamine treatment alongside psychiatric consultation.
Dr. Stepkovitch has a particular clinical interest in treatment-resistant depression and the thoughtful integration of neuromodulation and rapid-acting treatments into comprehensive psychiatric care.
His approach begins with diagnosis rather than procedure selection. For patients referred for TMS, ketamine, or Spravato, the consultation is an opportunity to reconsider the diagnosis, previous treatment, remaining symptoms, functional impairment, and the evidence supporting available options before deciding what should happen next.
That philosophy extends throughout treatment. At CNY Psychiatry, IV ketamine and Spravato treatments include direct psychiatric assessment rather than functioning solely as medication-administration visits. Treatment response is evaluated not only through symptom measures but through changes in function, relationships, interests, work, and everyday life.
Dr. Stepkovitch was also an early adopter of accelerated TMS. CNY Psychiatry was among the early practices in New York State to offer accelerated treatment and currently provides an intensive 50-session accelerated TMS program informed by the evolving accelerated-neuromodulation literature.
His current clinical interests also include combined TMS and ketamine treatment for selected patients with difficult-to-treat depression and the integration of ketamine with evidence-based trauma treatment. CNY Psychiatry’s Ketamine + Written Exposure Therapy program partners with WET-trained community therapists to coordinate biological and trauma-focused treatment while preserving the patient’s existing therapeutic relationship.
A central principle of Dr. Stepkovitch’s work is that advanced treatments should remain part of psychiatry rather than becoming isolated procedures.
“The goal isn’t to provide the newest or most intensive treatment. It’s to understand why someone hasn’t gotten better and determine what gives that individual the best opportunity for recovery.”
Clinical Interests:
Treatment-Resistant Depression • TMS & Accelerated TMS • IV Ketamine • Spravato® • Interventional Psychiatry • Difficult-to-Treat Mood Disorders
